D. E. Shaw & Co., Inc. Kempharm, Inc Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Kempharm, Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 189,313 shares of KMPH stock, worth $935,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,313
Previous 27,370
591.68%
Holding current value
$935,206
Previous $135,000
592.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding KMPH
# of Institutions
132Shares Held
32.6MCall Options Held
379KPut Options Held
611K-
Woodline Partners LP San Francisco, CA4.62MShares$22.8 Million0.13% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.17MShares$20.6 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$14.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.96MShares$9.67 Million0.22% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...